ask="2.90"
ask_size="700"
average_daily_volume="89760"
bid="2.30"
bid_size="300"
book_value="2.84"
change="+0.20"
change_from_200_day_moving_average="-1.41"
change_from_50_day_moving_average="0.10"
change_from_52_week_high="-3.89"
change_From_52_week_low="0.50"
change_in_percent="+8.70%"
close="2.50"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.04"
ebitda="-37.85M"
eps_estimate_current_year="-1.83"
eps_estimate_next_quarter="-0.30"
eps_estimate_next_year="-1.12"
ex_dividend_date="N/A"
float_shares="10701000"
high="2.50"
high_52_weeks="6.39"
last_trade_date="2/15/2017"
last_trade_price="2.50"
last_trade_size="149"
last_trade_time="3:59pm"
low="2.35"
low_52_weeks="2.00"
market_capitalization="53.01M"
moving_average_200_day="3.91"
moving_average_50_day="2.40"
name="Strongbridge Biopharma plc"
notes="N/A"
one_year_target_price="14.33"
open="2.35"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-36.04%"
percent_change_from_50_day_moving_average="+4.15%"
percent_change_from_52_week_high="-60.88%"
percent_change_from_52_week_low="+25.00%"
previous_close="2.30"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="0.81"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="21205000"
short_ratio="0.76"
stock_exchange="NMS"
symbol="SBBP"
volume="106708"
weeks_range_52="2.00 - 6.39"
